Integrated therapy for locally advanced bladder cancer: Final report of a randomized trial of cystectomy plus adjuvant M-VAC versus cystectomy with both preoperative and postoperative M-VAC

Journal of Clinical Oncology

Volumn 19, Issue 20, 2001, Pages 4005-4013

  Millikan, R ^a   Dinney, C ^a   Swanson, D ^a   Sweeney, P ^a   Ro, J Y ^a   Smith, T L ^a   Williams, D ^a   Logothetis, C ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; DOXORUBICIN; METHOTREXATE; VINBLASTINE;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BLADDER CANCER; CANCER CHEMOTHERAPY; CANCER STAGING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYSTECTOMY; FEMALE; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PELVIS LYMPH NODE; PHASE 3 CLINICAL TRIAL; POSTOPERATIVE CARE; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

EID: 0035887279     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2001.19.20.4005     Document Type: Article

References (19)

1. Radical cystectomy for invasive bladder cancer: Contemporary results and remaining controversies
2. Predicting the survival of bladder carcinoma patients treated with radical cystectomy
3. Prognostic factors of outcome after radical cystectomy for bladder cancer: A retrospective study of a homogeneous patient cohort
4. Evaluation of clinical staging before cystectomy in transitional cell bladder carcinoma: A long-term follow-up of 276 consecutive patients
5. Adjuvant cyclophosphamide, doxorubicin, and cisplatin chemotherapy for bladder cancer: An update
6. The role of adjuvant chemotherapy following cystectomy for invasive bladder cancer: A prospective comparative trial
7. Adjuvant polychemotherapy of non-organ-confined bladder cancer after radical cystectomy revisited: Long-term results of a controlled prospective study and further clinical experience
8. A randomized trial of radical cystectomy versus radical cystectomy plus cisplatin, vinblastine and methotrexate chemotherapy for muscle invasive bladder cancer
9. Neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer - A randomized controlled trial
10. Optimal delivery of perioperative chemotherapy: Preliminary results of a randomized, prospective trial of preoperative and postoperative chemotherapy for invasive bladder carcinoma
11. Complications of radical cystectomy: Impact of the timing of perioperative chemotherapy
12. M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for advanced transitional cell carcinoma of the urothelium
13. Nonparametric estimation from incomplete observations
14. The value of pathologic factors in predicting cancer-specific survival among patients treated with radical cystectomy for transitional cell carcinoma of the bladder and prostate
15. Grading and staging of bladder carcinoma in transurethral resection specimens
16. Pelvic lymph node dissection can be curative in patients with node positive bladder cancers
17. Outcome of patients with grossly node positive bladder cancer after pelvic lymph node dissection and radical cystectomy
18. The value of pathologic factors in predicting cancer-specific survival among patients treated with radical cystectomy for transitional cell carcinoma of the bladder and prostate
19. Outcome of postchemotherapy surgery after treatment with methotrexate, vinblastine, doxorubicin, and cisplatin in patients with unresectable or metastatic transitional cell carcinoma